ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "diagnosis"

  • Abstract Number: 1954 • 2015 ACR/ARHP Annual Meeting

    How Can We Use Ultrasound in the Diagnosis and Management of Patients with Giant Cell Arteritis?

    Cristina Ponte1,2, Sophie Vaggers1, Jan Sznajd1, Lorraine O'Neill1, Jennifer Piper3, Jessica Gunn1, Kulveer Mankia1 and Raashid Luqmani1, 1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2Rheumatology and Metabolic Bone Diseases Department, Rheumatology Research Unit - IMM, Lisbon Academic Medical Centre, Lisbon, Portugal, 3Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Giant cell arteritis (GCA), the most common primary vasculitis, can cause irreversible blindness in 20-30% of untreated cases, but glucocorticoid therapy leads to significant…
  • Abstract Number: 1963 • 2015 ACR/ARHP Annual Meeting

    Specialty of Provider Referring for Temporal Artery Biopsy Affects the Likelihood of Giant Cell Arteritis (GCA) Diagnosis

    Lindsay Lally1 and Robert F. Spiera2, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Rheumatology, HSS, New York, NY

    Background/Purpose: Presenting signs/symptoms of GCA can be nonspecific and patients can initially present to a spectrum of clinical specialties.  While temporal artery biopsy (TAB) is…
  • Abstract Number: 2160 • 2015 ACR/ARHP Annual Meeting

    The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis: A Diagnostic Accuracy and Cost-Effectiveness Study

    Raashid Luqmani1, Ellen Lee2, Surjeet Singh3, Michael Gillett2, Wolfgang A. Schmidt4, Mike Bradburn2, Bhaskar Dasgupta5,6, Andreas P Diamantopoulos7, Wulf Forrester-Barker8, William Hamilton9, Shauna Masters10, Brendan McDonald11, Eugene McNally8, Colin T. Pease12, Jennifer Piper8, John Salmon13, Allan Wailoo2, Konrad Wolfe14, Andrew Hutchings15 and TABUL Study group, 1Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 2School of Health and Related Research, University of Sheffield, Sheffield, United Kingdom, 31Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 4Medical Center for Rheumatology and Clinical Immunology Berlin-Buch, Immanuel Krankenhaus Berlin, Berlin, Germany, 5Rheumatology, Southend University Hospital, Essex, United Kingdom, 6Southend University Hospital, Essex, United Kingdom, 7Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 8Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 9Primary Care, University of Exeter, Exeter, United Kingdom, 10Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science, University of Oxford, Oxford, United Kingdom, 11Department of Neuropathology and Ocular Pathology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, 12Rheumatology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom, 13Ophthalmology, Oxford University Hospitals NHS Trust, Oxford, United Kingdom, 14Department of Pathology, Southend University Hospital, Essex, United Kingdom, 15Health Services Research Unit, London School of Hygiene and Tropical Medicine, London, United Kingdom

    Background/Purpose: Giant cell arteritis (GCA) is a relatively common form of primary systemic vasculitis which if untreated can lead to permanent sight loss. It is…
  • Abstract Number: 2298 • 2015 ACR/ARHP Annual Meeting

    Misdiagnosis of Fibromyalgia (FM) As Axial Spondylarthritis (SpA): Lessons from Analysis of 26 Cases

    Dongfeng Liang, Jianglin Zhang and Feng Huang, Rheumatology, Chinese PLA General Hospital, Beijing, China

    Background/Purpose: Both patients with fibromyalgia (FM) and with axial spondyloarthritis (SpA) are suffering from pain.  The patients with axial SpA are mainly manifested as inflammatory…
  • Abstract Number: 407 • 2014 ACR/ARHP Annual Meeting

    Serum 14-3-3η Protein Supplements Traditional Rheumatoid Arthritis Biomarkers

    Olga Zhukov1, Jonnielyn Rivera1, Charles M. Rowland2, Joanna M. Popov1 and Stanley J. Naides3, 1Immunology, Quest Diagnostics Nichols Institute, San Juan Capistrano, CA, 2Bioinformatics, Celera, Alameda, CA, 3Immunology, Quest Diagnostics, San Juan Capistrano, CA

    Background/Purpose: The 14-3-3 family of chaperonin proteins consists of 7 isomers.  The tissue distribution of the 14-3-3η (eta) isoform is limited to synovial tissue and…
  • Abstract Number: 284 • 2014 ACR/ARHP Annual Meeting

    Single Hub and Access Point for Paediatric Rheumatology in Europe (SHARE)– Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Idiopathic Arthritis

    S.J. Vastert1, Victor Boom2, Jordi Anton3, Tamás Constantin4, Pavla Dolezalova5, Gerd Horneff6, Pekka Lahdenne7, Bo Magnusson8, Kirsten Minden9, K. Nistala10, Pierre Quartier11, Ingrida Rumba-Rozenfelde12, Nicolino Ruperto13, Vanessa Remy Piccolo14, Ricardo A. G. Russo15, Yosef Uziel16, Carine Wouters17, Alberto Martini18, Angelo Ravelli19, Helen Foster20 and Nico Wulffraat21, 1Pediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, 2Paediatric Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands, 3Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, 4Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, 5Paediatric Rheumatiology unit, 1st Faculty of Medicine, General University Hospital, Prague, Czech Republic, 6Asklepios Klinik Sankt Augustin, Sankt Augustin, Germany, 7Paediatrics, Helsinki University Central Hospital, Helsinki, Finland, 8Pediatric Rheumatology, Astrid Lindgren Children's Hospital, Stockholm, Sweden, 9Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, 10Centre for Rheumatology, University College London, London, United Kingdom, 11Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, 12University of Latvia, Riga, Latvia, 13Pediatria II,, Istituto Giannina Gaslini, Genoa, Italy, 14Pediatric Rheumatology, Hopital Necker Enfants Malades, Paris, France, 15Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina, 16Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, 17University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, 18Istituto Giannina Gaslini, Genova, Italy, 19University of Genova, Genova, Italy, 20Newcastle University, Newcastle, United Kingdom, 21Paediatric Immunology and Rheumatology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose Juvenile Idiopathic Arthritis (JIA) is one of the most common chronic pediatric rheumatic diseases (PRD). As is the case for most PRD's, evidence-based guidelines…
  • Abstract Number: 256 • 2014 ACR/ARHP Annual Meeting

    Characteristics of Pain in Fabry Disease

    Olivier Lidove1, Esther Noel2, Eric Hachulla3, Francis Gaches4, Claire Douillard5, Bernadette Darne6, Kim Heang Ly7, Christian Lavigne8, Agathe Masseau9, Laurent Aaron10, Boris Bienvenu11, Thierry Zenone12, Philippe Vitielli6, Vanessa Leguy-Seguin13 and Jean Marc Ziza14, 1Médecine interne, Hôpital Croix-Saint-Simon, PARIS, France, 2CHU de Strasbourg - Hopital Civil, Strasbourg, France, 3Faculté de Médecine Henri Warembourg, Université Lille Nord de France, Lille, France, 4Hopital Joseph Ducuing, Toulouse, France, 5CHU Lille, Lille, France, 6Monitoring Force, Maisons-Laffitte, France, 7CHU Dupuytren, Limoges, Limoges, France, 8CHU d'Angers, Angers, France, 9Internal Medicine Department, Nantes University Hospital, Nantes, France, 10Internal Medicine, Hôpital Jacques Coeur, Bourges, Bourges, France, 11Médecine interne, CHU Côte de Nacre, CAEN, France, 12CH de Valence, Valence, France, 13CHU Dijon, Dijon, France, 14Hopital Croix-Saint-Simon, Paris Cedex 20, France

    Background/Purpose Fabry disease (FD) is an X-linked disorder caused by a deficiency of lysosomal alpha-galactosidase A resulting in accumulation of glycosphingolipids. Clinical manifestations include a…
  • Abstract Number: 202 • 2014 ACR/ARHP Annual Meeting

    Is Schuss View Alone Enough for the Diagnosis of Femorotibial Osteoarthritis ? the Khoala Cohort Study

    Christian Roux1, Bernard Mazieres2, Evelyne Verrouil2, Anne-Christine Rat,3, Patrice Fardellone4, Bruno Fautrel5, Jacques Pouchot6, Alain Saraux7, Francis Guillemin8, Liana Euller Ziegler9 and Joel Coste10, 1Rhumatologie, Hopital Archet 1 - Université Nice Sophia Antipolis, Nice, France, 2CHU Toulouse, Toulouse, France, 3Université de Lorraine, Université Paris Descartes, Apemac, EA 4360, Nancy, France, 4Service de Rhumatologie, Hôpital Nord, C.H.U. d'Amiens, Amiens, France, 5CHU - Hôpital Pitié-Salpêtrière, Paris, France, 6Medecine Interne, Hopital Louis Mourier, Colombes, FRANCE, France, 7Rheumatology, CHU de la Cavale Blanche and Université Bretagne occidentale, Brest Cedex, France, 8INSERM, Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC) CIE6, Nancy, France, 9151 rte de St Antoine de Gines, CHU de Nice -Université Nice Sophia Antipolis, Nice, France, 10CHU Hotel Dieu, Paris, France

    Background/Purpose: Associating an anteroposterior (AP) extended-knee X-ray with a semiflexed AP or posteroanterior (PA) view is considered the gold standard for radiologically diagnosing tibiofemoral osteoarthritis…
  • Abstract Number: 2774 • 2014 ACR/ARHP Annual Meeting

    Why Leg Ulcers Do Not Heal? a Prospective Study Showing High Proportion of Small Vessel Vasculitis

    Vinod Ravindran1, Sunil Rajendran2 and Ranjish Vijayan2, 1National Hospital, Kozhikode, Kerala, India, 2PVS Hospital, Kozhikode, India

    Background/Purpose: Non healing cutaneous ulcers of lower limbs can have several different aetiologies [1]. It is likely that the patients with such ulcers would be…
  • Abstract Number: 2624 • 2014 ACR/ARHP Annual Meeting

    Impact of Provider Specialty on the Diagnosis and Management of Systemic Lupus Erythematosus in the American Indian/Alaska Native Population

    John McDougall Jr.1, Charles G. Helmick2, S. Sam Lim3, Caroline Gordon4 and Elizabeth Ferucci5, 1Department of Internal Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, 2National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, 3Emory University School of Medicine, Division of Rheumatology, Atlanta, GA, 4Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom, 5Alaska Native Medical Center, Anchorage, AK

    Background/Purpose Systemic lupus erythematosus (SLE) is a complex disease that is traditionally diagnosed and managed by specialists, typically rheumatologists.  Higher SLE prevalence in racial/ethnic minorities…
  • Abstract Number: 2279 • 2014 ACR/ARHP Annual Meeting

    Evidence Based Recommendations for Diagnosis and Management of Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS)

    Nienke ter Haar1, Paul Brogan2, Gilles Grateau3, Jordi Anton4, Karyl Barron5, Luca Cantarini6, Joost Frenkel7, Caroline Galeotti8, Veronique Hentgen9, Michael Hofer10, Tilmann Kallinich11, Isabelle Kone-Paut12, Jasmin Kuemmerle-Deschner13, Huri Ozdogan14, Seza Ozen15, Ricardo Russo16, Anna Simon17, Yosef Uziel18, Carine Wouters19, Brian Feldman20, Bas Vastert7, Nico Wulffraat21, Helen Lachmann22 and Marco Gattorno23, 1Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 3Service De Médecine Interne, Hopital Tenon, Paris, France, 4Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, 5NIH, Bethesda, MD, 6University of Siena, Siena, Italy, 7University Medical Center Utrecht, Utrecht, Netherlands, 8Bicêtre Hospital, University of Paris SUD, Paris, France, 9Versailles Hospital, Le Chesnay Cedex, France, 10Centre Multisite Romand de Rhumatologie Pediatrique, Lausanne, Switzerland, 11Charite, University Medicine Berlin, Berlin, Germany, 12Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France, 13Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, 14Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 15Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, 16Immunology & Rheumatology, Hospital De Pediatria, Buenos Aires, Argentina, 17Radboudumc, Nijmegen, Netherlands, 18Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, 19University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, 20Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 21Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, 22UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom, 23Istituto Giannina Gaslini, Genova, Italy

    Background/Purpose Tumor necrosis factor receptor-1 associated periodic syndrome (TRAPS) is a rare hereditary autoinflammatory syndrome that can lead to significant morbidity. Evidence-based guidelines are lacking…
  • Abstract Number: 2282 • 2014 ACR/ARHP Annual Meeting

    Evidence Based Recommendatinos for Diagnosis and Management of Mevalonate Kinase Deficiency (MKD)

    Nienke ter Haar1, Jerold Jeyaratnam2, Jordi Anton3, Caroline Galeotti4, Karyl Barron5, Paul Brogan6, Luca Cantarini7, Marco Gattorno8, Gilles Grateau9, Veronique Hentgen10, Michael Hofer11, Tilmann Kallinich12, Isabelle Kone-Paut13, Jasmin Kuemmerle-Deschner14, Helen Lachmann15, Huri Ozdogan16, Seza Ozen17, Ricardo Russo18, Yosef Uziel19, Carine Wouters20, Brian Feldman21, Bas Vastert2, Nico Wulffraat22, Anna Simon23 and Joost Frenkel2, 1Laboratory for Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2University Medical Center Utrecht, Utrecht, Netherlands, 3Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, 4Bicêtre Hospital, University of Paris SUD, Paris, France, 5NIH, Bethesda, MD, 6Rheumatology Unit, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 7University of Siena, Siena, Italy, 8Istituto Giannina Gaslini, Genova, Italy, 9Service De Médecine Interne, Hopital Tenon, Paris, France, 10Versailles Hospital, Le Chesnay Cedex, France, 11Centre Multisite Romand de Rhumatologie Pediatrique, Lausanne, Switzerland, 12Charite, University Medicine Berlin, Berlin, Germany, 13Department of Pediatric Rheumatology, Reference Centre for Autoinflammatory Disorders CEREMAI, Bicêtre Hospital, University of Paris SUD, Paris, France, 14Pediatrics, University Hospital Tuebingen, Tuebingen, Germany, 15UK National Amyloidosis Centre, University College London Medical School, London, United Kingdom, 16Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 17Deptartment. of Pediatric Rheumatology, Hacettepe University, Ankara, Turkey, 18Immunology & Rheumatology, Hospital De Pediatria, Buenos Aires, Argentina, 19Tel-Aviv University, Sackler School of Medicine, Tel-Aviv, Israel, 20University of Leuven, Laboratory of Pediatric Immunology, University Hospital Leuven, Leuven, Belgium, 21Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 22Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, 23Radboudumc, Nijmegen, Netherlands

    Background/Purpose Mevalonate kinase deficiency (MKD) is a rare hereditary autoinflammatory syndrome that can lead to significant morbidity. Evidence-based guidelines are lacking and management is mostly…
  • Abstract Number: 1696 • 2014 ACR/ARHP Annual Meeting

    Left Atrial Area Measurement Is Useful for Evaluating Left Ventricular Diastolic Dysfunction Coexisting with Pulmonary Arterial Hypertension Associated with Systemic Sclerosis

    Sumiaki Tanaka1, Nobuhiro Sho2, Tatsuo Nagai3, Yoshiyuki Arinuma2 and Shunsei Hirohata1, 1Int Med/Rheumatol & Infec Dis, Kitasato University School of Medicine, Sagamihara, Japan, 2Kitasato University School of Medicine, Sagamihara, Japan, 3Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan

    Background/Purpose: Pulmonary arterial hypertension (PAH) is a crucial organ involvement affecting survival of patients with connective tissue disease (CTDs), such as systemic sclerosis (SSc), systemic…
  • Abstract Number: 1329 • 2014 ACR/ARHP Annual Meeting

    Comparison of Clinical and Serological Features of Childhood Sjögren Syndrome Based on the Presence or Absence of Parotitis

    Jay Mehta1, Namrata Singh2 and Scott Lieberman3, 1Pediatrics, Children's Hospital at Montefiore/Albert Einstein College of Medicine, Bronx, NY, 2Medicine, University of Iowa, Iowa City, IA, 3Pediatrics (Division of Rheumatology), University of Iowa Children's Hospital, Iowa City, IA

    Background/Purpose: Sjögren syndrome is a complex autoimmune disease that affects lacrimal and salivary glands with the potential to cause damage to other organs. Diagnosis of…
  • Abstract Number: 1325 • 2014 ACR/ARHP Annual Meeting

    Single Hub and Access Point for Pediatric Rheumatology in Europe (SHARE): Evidence Based Recommendations for Diagnosis and Treatment of Juvenile Localized Scleroderma and Juvenile Systemic Sclerosis

    Bas Vastert1, Roberta Culpo2, Jordi Anton3, Tadej Avcin4, Eileen Baildam5, Christina Boros6, Tamás Constantin7, Jeff Chaitow8, Pavla Dolezalova9, Ozgur Kasapcopur10, Sheila Oliveira11, Clarissa Pilkington12, Annet van Royen-Kerkhof13, Ricardo A. G. Russo14, Claudia Saad-Magalhaes15, Natasa Toplak16, Angelo Ravelli17, Nico Wulffraat18, Ivan Foeldvari19 and Francesco Zulian20, 1University Medical Center Utrecht, Utrecht, Netherlands, 2Department of Pediatrics., University of Padua, Padua, Italy, 3Pediatric Rheumatology Unit. Hospital Sant Joan de Déu. Universitat de Barcelona, Barcelona, Spain, 4Pediatric Rheumatology, University Children´s Hospital, Ljubjana, Slovenia, 5Paediatric Rheumatology, Alder Hey Children's Foundation NHS Trust, Liverpool, United Kingdom, 6University of Adelaide, Adelaide, Australia, 7Pediatric Rheumatology, University Childrens Hospital, Budapest, Hungary, 8The Children’s Hospital Westmead, Sydney, Australia, 9Department of Paediatrics and Adolescent Medicine, Charles University, Prague, Czech Republic, 10University Cerrahpasa Faculty of Medicine, Istanbul, Turkey, 11Pediatric Rheumatology, Universidade F Rio De Janeiro, Rio De Janeiro, Brazil, 12Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, 13Paediatric Immunology and Rheumatology, University Medical Centre Utrecht - Wilhelmina Children's Hospital, Utrecht, Netherlands, 14Immunology & Rheumatology, Hospital de Pediatria Garrahan, Buenos Aires, Argentina, 15Faculdade de Medicina de Botucatu, Botucatu, Brazil, 16Pediatric Rheumatology, University Medical Center, Ljubliana, Slovenia, 17Istituto Giannina Gaslini and University of Genova, Genova, Italy, 18Pediatric rheumatology, Wilhelmina Children's Hospital/ UMC Utrecht, Utrecht, Netherlands, 19Department of Pediatric Rheumatology, Hamburger Zentrum für Kinder und Jugendrheumatologie, Hamburg, Germany, 20Pediatrics/Rheumatology Div, University of Padua, Padua, Italy

    Background/Purpose Juvenile Localized Scleroderma (JLS) and Juvenile Systemic Sclerosis (JSSc) form a group of rare pediatric diseases that can lead to significant morbidity. Evidence-based guidelines…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology